CRSP icon

CRISPR Therapeutics

444 hedge funds and large institutions have $3.47B invested in CRISPR Therapeutics in 2022 Q1 according to their latest regulatory filings, with 72 funds opening new positions, 170 increasing their positions, 97 reducing their positions, and 65 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
444
Holders Change
Holders Change %
0%
% of All Funds
7.03%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
72
Increased
170
Reduced
97
Closed
65
Calls
$149M
Puts
$156M
Net Calls
-$6.94M
Net Calls Change
-$24M
Name Holding Trade Value Shares
Change
Shares
Change %
GC
376
Gould Capital
Washington
$6K
GIA
377
GHP Investment Advisors
Colorado
$6K +$6K +100 New
DHGWA
378
Dixon Hughes Goodman Wealth Advisors
North Carolina
$6K +$6K +100 New
HPC
379
HM Payson & Co
Maine
$5K
MHR
380
Matthew Hamilton Rosenberg
$5K
BA
381
Bellwether Advisors
Nebraska
$5K
PK
382
Pflug Koory
Nebraska
$5K
PCFFS
383
Pacific Center for Financial Services
California
$5K
CP
384
Corbenic Partners
Pennsylvania
$4K -$44K -660 -92%
PGAM
385
Princeton Global Asset Management
New Jersey
$4K -$13.7K -240 -77%
AIP
386
Ahrens Investment Partners
Louisiana
$4K
RA
387
Rise Advisors
New York
$4K
LF
388
Lee Financial
Texas
$4K
GI
389
Gradient Investments
Minnesota
$4K +$1.59K +25 +66%
DAC
390
Dividend Assets Capital
South Carolina
$4K +$1.81K +28 +82%
CAGAS
391
Capital Advisory Group Advisory Services
Minnesota
$4K +$4K +62 New
AP
392
Arlington Partners
Alabama
$4K +$4K +69 New
First Manhattan
393
First Manhattan
New York
$3K -$38K -634 -93%
GRP
394
Global Retirement Partners
California
$3K -$6.42K -107 -68%
FAG
395
Fortitude Advisory Group
Washington
$3K -$5.88K -100 -66%
MS
396
Mizuho Securities
Japan
$3K -$67 -1 -2%
TFP
397
Tilia Fiduciary Partners
North Carolina
$3K
TFA
398
Toth Financial Advisory
Virginia
$3K
MWA
399
Moser Wealth Advisors
Washington
$3K
WBC
400
West Branch Capital
Massachusetts
$3K